Biosynthesis of tetrahydrobiopterin starts from guanosine triphosphate
by the action of guanosine triphosphate cyclohydrolase I, which yield
s the first intermediate, 7,8-dihydroneopterin triphosphate. This comp
ound is then converted by subsequent enzymes, 6-pyruvoyl tetrahydropte
rin synthase and sepiapterin reductase, to tetrahydrobiopterin, the bi
ologically active metabolite. Cytokines such as gamma-interferon or tu
mor necrosis factor-alpha strongly stimulate the activity of guanosine
triphosphate cyclohydrolase I in murine and human cells, yielding a p
otentiation of intracellular tetrahydrobiopterin concentrations. In hu
man cells, particularly in human monocytes and macrophages, the low ac
tivity of 6-pyruvoyl tetrahydropterin synthase leads to the additional
accumulation of neopterin derivatives, which leak from the cells afte
r dephosphorylation and are found increased in body fluids of humans w
ith diseases challenging cell-mediated immunity. A functional role for
the stimulation of tetrahydrobiopterin biosynthesis by cytokines is t
he formation of a limiting cofactor required for the enzymatic convers
ion of L-arginine to citrulline and nitric oxide.